Efficacy and safety of neoadjuvant bevacizumab plus chemotherapy in locally advanced gastric cancer patients: a retrospective, comparative study.

World J Surg Oncol · 2025 · PMC11773743 · PMID 39875999

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

did not reach statistical significanceno p-value reported

75.0%, P = 0.356) did not reach statistical significance between the two groups, but they showed an increased trend numerically in the bevacizumab plus chemo group versus the chemo group.

also in 111,027 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.